Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent ...

DexCom and Abbott Reach Settlement in Global Patent Dispute. DexCom, Inc. (DXCM, Financial) has announced a significant development in its ongoing global patent litigation with Abbott Diabetes Care, ...

Abstract: The amorphous wire demonstrate good soft magnetic properties and the giant magnetoimpedance effect (GMI). However, the amorphous wire with diameter ranging from several micrometers to ...

ESP32-based portable blood glucose visualisation device with e-ink display. Utilizes Dexcom API, BME280, and VCNL4040 sensors. Developed in C++ for low power, long battery life.

Netherlands consortium advances cryogenic composites testing, tank designs and manufacturing including AFP, hybrid winding, welding of tank components and integrated SHM and H2 sensors for ...

Furthermore, you'd generally like to see... Investing.com -- Baird upgraded DexCom Inc (NASDAQ:DXCM). to "Outperform" from "Neutral," citing progress in U.S. sales and upcoming catalysts.